Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016 (2016), Article ID 6756859, 13 pages
http://dx.doi.org/10.1155/2016/6756859
Review Article

Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis

1Department of Colorectal Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, China
2Oncology Department, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 360000, China

Received 30 June 2015; Revised 9 November 2015; Accepted 10 November 2015

Academic Editor: Ralf-Dieter Hofheinz

Copyright © 2016 Xiao-Jie Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. T. Monson, M. R. Weiser, W. D. Buie, G. J. Chang, and J. F. Rafferty, “Practice parameters for the management of rectal cancer (revised),” Diseases of the Colon and Rectum, vol. 56, no. 5, pp. 535–550, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. N. N. Rahbari, H. Elbers, V. Askoxylakis et al., “Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials,” Annals of Surgical Oncology, vol. 20, no. 13, pp. 4169–4182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. T. Martin, H. M. Heneghan, and D. C. Winter, “Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer,” The British Journal of Surgery, vol. 99, no. 7, pp. 918–928, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Weiser, H.-M. Quah, J. Shia et al., “Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection,” Annals of Surgery, vol. 249, no. 2, pp. 236–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L.-J. Kuo, M.-C. Liu, J. J.-M. Jian et al., “Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?” Annals of Surgical Oncology, vol. 14, no. 10, pp. 2766–2772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. G. Moore, A. E. Gittleman, B. D. Minsky et al., “Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection,” Diseases of the Colon and Rectum, vol. 47, no. 3, pp. 279–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. C.-L. Tran, S. Udani, A. Holt, T. Arnell, R. Kumar, and M. J. Stamos, “Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer,” The American Journal of Surgery, vol. 192, no. 6, pp. 873–877, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S.-B. Lim, H. S. Choi, S.-Y. Jeong et al., “Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers,” Annals of Surgery, vol. 248, no. 2, pp. 243–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Tulchinsky, E. Shmueli, A. Figer, J. M. Klausner, and M. Rabau, “An interval > 7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer,” Annals of Surgical Oncology, vol. 15, no. 10, pp. 2661–2667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Habr-Gama, R. O. Perez, I. Proscurshim et al., “Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?” International Journal of Radiation Oncology, Biology, Physics, vol. 71, no. 4, pp. 1181–1188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. F. de Campos-Lobato, D. P. Geisler, A. D. L. Moreira, L. Stocchi, D. Dietz, and M. F. Kalady, “Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery,” Journal of Gastrointestinal Surgery, vol. 15, no. 3, pp. 444–450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Evans, D. Tait, I. Swift et al., “Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?” Diseases of the Colon and Rectum, vol. 54, no. 10, pp. 1251–1259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. M. Wolthuis, F. Penninckx, K. Haustermans et al., “Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome,” Annals of Surgical Oncology, vol. 19, no. 9, pp. 2833–2841, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. D. A. Sloothaak, D. E. Geijsen, N. J. van Leersum et al., “Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer,” British Journal of Surgery, vol. 100, no. 7, pp. 933–939, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. H. Jeong, H. B. Lee, H. Hur, B. S. Min, S. H. Baik, and N. K. Kim, “Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer,” Journal of the Korean Surgical Society, vol. 84, no. 6, pp. 338–345, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. C. B. Fang, C. M. C. D. N. Gomes, F. B. Formiga, V. A. Fonseca, M. P. Carvalho, and W. A. Klug, “Is the delayed surgery after neoadjuvant chemoradiation beneficial for locally advanced rectal cancer?” ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), vol. 26, no. 1, pp. 31–35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. F. A. Calvo, V. Morillo, M. Santos et al., “Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomes,” Journal of Cancer Research and Clinical Oncology, vol. 140, no. 10, pp. 1651–1660, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. W.-G. Zeng, Z.-X. Zhou, J.-W. Liang et al., “Impact of interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer on surgical and oncologic outcome,” Journal of Surgical Oncology, vol. 110, no. 4, pp. 463–467, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. K.-Y. You, R. Huang, L.-N. Zhang et al., “Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 4, pp. 719–728, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Sirohi, S. G. Barreto, S. Patkar et al., “Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: does timing of surgery really matter?” Indian Journal of Medical and Paediatric Oncology, vol. 35, no. 4, pp. 263–266, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Francois, C. J. Nemoz, J. Baulieux et al., “Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial,” Journal of Clinical Oncology, vol. 17, no. 8, pp. 2396–2402, 1999. View at Google Scholar · View at Scopus
  22. J. H. Lefevre, A. Rousseau, M. Svrcek, Y. Parc, T. Simon, and E. Tiret, “A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design,” BMC Cancer, vol. 13, article 417, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Garcia-Aguilar, D. D. Smith, K. Avila et al., “Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial,” Annals of Surgery, vol. 254, no. 1, pp. 97–102, 2011. View at Publisher · View at Google Scholar
  24. D. E. Stein, N. N. Mahmoud, P. R. Anné et al., “Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma,” Diseases of the Colon and Rectum, vol. 46, no. 4, pp. 448–453, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Harris, “Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer (Br J Surg 2013; 100: 933–939),” British Journal of Surgery, vol. 100, no. 7, pp. 939–940, 2013. View at Google Scholar
  26. C. Dolinsky, N. Mahmoud, R. Mick et al., “Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer,” International Journal of Radiation Oncology, Biology, Physics, vol. 63, article S277, 2005. View at Google Scholar
  27. D. Pettersson, E. Lörinc, T. Holm et al., “Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer,” British Journal of Surgery, vol. 102, no. 8, pp. 972–978, 2015. View at Publisher · View at Google Scholar
  28. R. Pach, J. Kulig, P. Richter, T. Gach, M. Szura, and T. Kowalska, “Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer—treatment results at 5-year follow-up,” Langenbeck's Archives of Surgery, vol. 397, no. 5, pp. 801–807, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Latkauskas, H. Pauzas, I. Gineikiene et al., “Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery,” Colorectal Disease, vol. 14, no. 3, pp. 294–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Bujko, A. Nasierowska-Guttmejer, L. Wyrwicz et al., “Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study,” Radiotherapy & Oncology, vol. 107, no. 2, pp. 171–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Petrelli, G. Sgroi, E. Sarti, and S. Barni, “Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies,” Annals of Surgery, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Garcia-Aguilar, O. S. Chow, D. D. Smith et al., “Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial,” The Lancet Oncology, vol. 16, no. 8, pp. 957–966, 2015. View at Publisher · View at Google Scholar
  33. S. Huerta, “Interval between neoadjuvant chemoradiation and surgery for the management of rectal cancer,” Journal of Gastrointestinal Surgery, vol. 15, no. 7, p. 1292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H. R. Withers and K. Haustermans, “Where next with preoperative radiation therapy for rectal cancer?” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 2, pp. 597–602, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. W. Motson, J. S. Khan, T. H. A. Arulampalam, R. C. T. Austin, N. Lacey, and B. Sizer, “Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer,” Surgical Endoscopy, vol. 25, no. 6, pp. 1753–1760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Hottenrott, “Timing of laparoscopic surgery in the neoadjuvant treatment of rectal cancer,” Surgical Endoscopy, vol. 26, no. 3, pp. 884–885, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. D. Foster, E. L. Jones, S. Falk, E. J. Cooper, and N. K. Francis, “Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature,” Diseases of the Colon and Rectum, vol. 56, no. 7, pp. 921–930, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Maas, P. J. Nelemans, V. Valentini et al., “Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data,” The Lancet Oncology, vol. 11, no. 9, pp. 835–844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M. H. Ihn, Y. H. Kim, D.-W. Kim et al., “Effects of preoperative chemoradiotherapy on the likelihood of sphincter preservation surgery in locally advanced distal rectal cancer: a longitudinal study based on pelvic magnetic resonance imaging,” Annals of Surgical Oncology, vol. 22, no. 7, pp. 2159–2167, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Sauer, H. Becker, W. Hohenberger et al., “Preoperative versus postoperative chemoradiotherapy for rectal cancer,” The New England Journal of Medicine, vol. 351, no. 17, pp. 1731–1740, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Sauer, T. Liersch, S. Merkel et al., “Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years,” Journal of Clinical Oncology, vol. 30, no. 16, pp. 1926–1933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Pericay, X. Serra-Aracil, J. Ocaña-Rojas et al., “Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer,” Clinical & Translational Oncology, 2015. View at Publisher · View at Google Scholar
  43. M. Rupinski, M. Szczepkowski, M. Malinowska et al., “Watch and wait policy after preoperative radiotherapy for rectal cancer; Management of residual lesions that appear clinically benign,” European Journal of Surgical Oncology, 2015. View at Publisher · View at Google Scholar
  44. J. J. Smith, O. S. Chow, M. J. Gollub et al., “Organ preservation in rectal adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management,” BMC Cancer, vol. 15, article 767, 2015. View at Publisher · View at Google Scholar